课题基金 / 基金详情

2006 Grover Conference on the Pulmonary Circulation - Rho Family GTPases

2006 Grover Conference on the Pulmonary Circulation - Rho Family GTPases
2006 Grover 肺循环会议 - Rho 家族 GTPases
批准号:
7112851
负责人:
KAREN A. FAGAN
金额:
$2.9万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-05 至 2007-03-31

项目摘要

项目成果

KAREN A. FAGAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): This application requests funding to support the 2006 Graver Conference on the Pulmonary Circulation entitled "Rho Family GTPases in Pulmonary Vascular Pathophysiology." This conference seeks to integrate state of the art bench research with clinical problems that are leading causes of morbidity and mortality from lung disease. The important roles Rho family GTPases (e.g. RhoA, Cdc42, and Rac1) play in lung biology and pathology are rapidly emerging. These signaling molecules have been implicated in a wide variety of cellular functions (contraction, permeability, inflammation, proliferation, migration, gene expression, differentiation) and are emerging as therapeutic targets in systemic and pulmonary vascular diseases. Indeed, the pleiotropic statins may act in part by inhibiting the activation of Rho GTPases. Inhibitors of Rho-kinase are available for in trials for treatment of cerebral and coronary artery vasospasm. The multifaceted role that Rho GTPases play in the pulmonary circulation is evolving toward treatments for pulmonary hypertension, ARDS, pulmonary edema, etc. However, there has not yet been a single, comprehensive conference to promote interaction and exchange of ideas amongst investigators interested in Rho GTPases in lung biology and pathology. Specifically, the 2006 Grover Conference seeks to provide a forum for experts in the cellular biology of Rho GTPases and in lung and vascular biology to rigorously address the: (1) Cell biology of Rho family GTPases including activation, signaling, etc., (2) Regulation of pulmonary vascular tone and activity through Rho family GTPase signaling, i.e., calcium sensitization and smooth muscle contraction, endothelial permeability, (3) Recruitment and activation of inflammatory cells to the lung following injury, etc., and (4) Rho family GTPases as therapeutic targets in medicine (e.g. pulmonary hypertension, ARDS, etc.). The 2006 Grover Conference will be the 13th in this series, representing the longest-standing conference on the pulmonary circulation. Equal time is given to presentation and discussion to optimize interaction. The conference will be held at the Lost Valley Ranch in Sedalia, CO September 6-10, 2006. The ranch is an intimate setting that encourages interaction between scientists and clinicians. We are requesting funding to support travel and lodging for invited speakers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Grover Conference on Risk Factors in Pulmonary Hypertension
  • 批准号:
    8130165
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    2011
  • 负责人:
    KAREN A. FAGAN
  • 依托单位:
CORE--ANIMAL
  • 批准号:
    7371915
  • 项目类别:
  • 资助金额:
    $15.94万
  • 财政年份:
    2007
  • 负责人:
    KAREN A. FAGAN
  • 依托单位:
Genetics of Pulmonary Hypertension in Mice
  • 批准号:
    7005837
  • 项目类别:
  • 资助金额:
    $16.64万
  • 财政年份:
    2005
  • 负责人:
    KAREN A. FAGAN
  • 依托单位:
Pulmonary Hypertension following Intermittent Hypoxia
  • 批准号:
    6577629
  • 项目类别:
  • 资助金额:
    $28.34万
  • 财政年份:
    2003
  • 负责人:
    KAREN A. FAGAN
  • 依托单位:
海外基金